SOCIAL QUESTIONS|health|pharmaceutical industry
- airí cógasdinimiciúil Tagairt "'Amifampridine SERB, INN-amifampridine. Iarscríbhinn I - Achoimre ar Shaintréithe an Táirge,' an Ghníomhaireacht Leigheasra Eorpach, https://www.ema.europa.eu/en/documents/product-information/amifampridine-serb-epar-product-information_ga.pdf [21.22.2023]Faomhadh an téarma seo mar chuid de Thionscadal Lex"
- ga
- Comhthéacs 'Déanfar tuairisciú mionsonraithe ar airíonna cógasdinimiciúla a bhaineann leis an éifeacht theiripeach a thuairisciú i gCuid 4A den sainchomhad.' Tagairt "Rialachán Tarmligthe (AE) 2021/805 lena leasaítear Iarscríbhinn II a ghabhann le Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle, CELEX:32021R0805/GA"
- pharmacodynamic property | pharmacodynamic parameter
- en
- Sainmhíniú "any characteristic of the relationship between a drug and its pharmacologic effect (pharmacodynamics)" Tagairt "COM-Terminology Coordination, based on: EMA. SmPC Advisory Group. 'Section 5.1: Pharmacodynamic properties' (27.2.2023) Rev. 1 SmPC training presentation"
- Nóta "See also: - dose-response relationship (narrower)- therapeutic index (narrower) "